1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Companion Diagnostics Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Companion Diagnostics Market Revenues & Volume, 2022 & 2032F |
3.3 Poland Companion Diagnostics Market - Industry Life Cycle |
3.4 Poland Companion Diagnostics Market - Porter's Five Forces |
3.5 Poland Companion Diagnostics Market Revenues & Volume Share, By Technology Type, 2022 & 2032F |
3.6 Poland Companion Diagnostics Market Revenues & Volume Share, By Indication, 2022 & 2032F |
4 Poland Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in Poland |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Rising adoption of companion diagnostics for accurate treatment decisions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 Limited awareness and understanding of companion diagnostics among healthcare professionals and patients in Poland |
5 Poland Companion Diagnostics Market Trends |
6 Poland Companion Diagnostics Market, By Types |
6.1 Poland Companion Diagnostics Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Companion Diagnostics Market Revenues & Volume, By Technology Type, 2022-2032F |
6.1.3 Poland Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2022-2032F |
6.1.4 Poland Companion Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2022-2032F |
6.1.5 Poland Companion Diagnostics Market Revenues & Volume, By Next Generation Sequencing (NGS), 2022-2032F |
6.1.6 Poland Companion Diagnostics Market Revenues & Volume, By In Situ Hybridization, 2022-2032F |
6.1.7 Poland Companion Diagnostics Market Revenues & Volume, By Others, 2022-2032F |
6.2 Poland Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Poland Companion Diagnostics Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.3 Poland Companion Diagnostics Market Revenues & Volume, By Neurology, 2022-2032F |
6.2.4 Poland Companion Diagnostics Market Revenues & Volume, By Others, 2022-2032F |
7 Poland Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Poland Companion Diagnostics Market Export to Major Countries |
7.2 Poland Companion Diagnostics Market Imports from Major Countries |
8 Poland Companion Diagnostics Market Key Performance Indicators |
8.1 Number of clinical trials incorporating companion diagnostics in Poland |
8.2 Adoption rate of companion diagnostics in oncology practices |
8.3 Investment in research and development of companion diagnostics technologies |
9 Poland Companion Diagnostics Market - Opportunity Assessment |
9.1 Poland Companion Diagnostics Market Opportunity Assessment, By Technology Type, 2022 & 2032F |
9.2 Poland Companion Diagnostics Market Opportunity Assessment, By Indication, 2022 & 2032F |
10 Poland Companion Diagnostics Market - Competitive Landscape |
10.1 Poland Companion Diagnostics Market Revenue Share, By Companies, 2025 |
10.2 Poland Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |